Kaiser Permanente's New Technologies Committee: an approach to assessing technology.
Kaiser Permanente's New Technologies Committee reviews emerging technologies, evaluates their status as experimental or nonexperimental, and recommends coverage under specified circumstances. Kaiser Permanente developed a model for consensus and policy formation in its handling of the case of chorionic villus sampling, a now preferred alternative to amniocentesis for the detection of fetal defects.